ZeroStack (ZSTK) Aandelenoverzicht
ZeroStack Corp. houdt zich via haar dochteronderneming Phatebo GmbH bezig met de distributie van farmaceutische producten in Duitsland. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 2/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 3/6 |
| Dividenden | 0/6 |
ZSTK Community Fair Values
Create NarrativeSee what 8 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
ZeroStack Corp. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$4.28 |
| 52 Week Hoogtepunt | US$47.00 |
| 52 Week Laag | US$3.72 |
| Bèta | 1.86 |
| 1 maand verandering | -42.92% |
| 3 maanden verandering | -48.56% |
| 1 Jaar Verandering | -84.39% |
| 3 jaar verandering | -97.80% |
| 5 jaar verandering | -99.86% |
| Verandering sinds IPO | -99.89% |
Recent nieuws en updates
ZSTK: Forward Share Split Authorization Will Drive Future Upside Potential
Analysts have adjusted their price target on ZeroStack to $11.00. The change reflects updated views on discount rates and profit margin expectations, while fair value and future P/E assumptions remain steady.ZSTK: Forward Share Split Authorization Will Support Future Upside Potential
Analysts have raised their price target on ZeroStack to $11.00, citing a slightly higher profit margin outlook and a lower discount rate in their updated valuation work. What's in the News Flora Growth Corp.Recent updates
ZSTK: Forward Share Split Authorization Will Drive Future Upside Potential
Analysts have adjusted their price target on ZeroStack to $11.00. The change reflects updated views on discount rates and profit margin expectations, while fair value and future P/E assumptions remain steady.ZSTK: Forward Share Split Authorization Will Support Future Upside Potential
Analysts have raised their price target on ZeroStack to $11.00, citing a slightly higher profit margin outlook and a lower discount rate in their updated valuation work. What's in the News Flora Growth Corp.FLGC: Forward Share Split Authorization Will Support Future Upside Potential
Analysts have reduced their fair value estimate for Flora Growth from $20.50 to $11.00, citing updated assumptions that now reflect a steeper projected revenue decline of 24.87% along with a slightly lower discount rate and essentially unchanged profit margin and future P/E inputs. What's in the News Shareholders approved giving the board authority to change the company name to ZeroStack Corp.Flora Growth Corp. (NASDAQ:FLGC) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
To the annoyance of some shareholders, Flora Growth Corp. ( NASDAQ:FLGC ) shares are down a considerable 26% in the...FLGC: Forward Share Split And Preferred Share Authorization Will Drive Upside
Analysts now place their price target for Flora Growth at US$20.50, unchanged from the prior US$20.50. They cite only marginal tweaks to inputs, such as a slightly lower discount rate, while keeping revenue growth and profit margin expectations effectively stable.FLGC: Forward Share Split And Preferred Shares Will Support Upside Potential
Analysts have modestly raised their price target on Flora Growth, increasing the estimate by $0.00 to reflect a slightly higher perceived risk profile driven by an uptick in the discount rate, while keeping long term growth and profitability expectations essentially unchanged. What's in the News Shareholders approved giving the board authority to change the company name to ZeroStack Corp., create a new class of preferred shares, and implement a forward share split of between 2:1 and 10:1.FLGC: Forward Share Split And New Capital Raising Will Fuel Upside Potential
Analysts have modestly raised their price target on Flora Growth to $20.50, citing a slightly lower perceived risk reflected in a reduced discount rate, while maintaining stable expectations for revenue growth and profit margins. What's in the News Flora Growth has convened a special shareholders meeting for December 19, 2025 in Toronto to vote on corporate actions including capital structure and governance items (company filing).FLGC: Forward Share Split and Equity Offering Will Drive Renewed Momentum
Analysts have significantly lowered their price target for Flora Growth from $93.00 to $20.50. They cite revised expectations for revenue growth and a slightly reduced discount rate as key factors influencing this adjustment.Flora Growth Corp.'s (NASDAQ:FLGC) Shares Leap 26% Yet They're Still Not Telling The Full Story
Flora Growth Corp. ( NASDAQ:FLGC ) shareholders are no doubt pleased to see that the share price has bounced 26% in the...US Cannabis And European Beverage Markets Will Create Opportunities
Flora Growth’s consensus Analyst Price Target was notably reduced from $156.00 to $93.00 due to continued gross margin pressure, underwhelming operational progress despite a strategic shift toward branded U.S. and European opportunities, and softer-than-expected recent results, although long-term confidence in management’s direction remains. Analyst Commentary Gross margin pressure negatively impacted Flora Growth's bottom line results this quarter.Investors Aren't Buying Flora Growth Corp.'s (NASDAQ:FLGC) Revenues
Flora Growth Corp.'s ( NASDAQ:FLGC ) price-to-sales (or "P/S") ratio of 0.3x might make it look like a buy right now...
US Cannabis And European Beverage Markets Will Create Opportunities
Regulatory changes and strategic U.S. expansion could significantly enhance Flora's presence and revenue growth in the cannabis industry.Is Flora Growth (NASDAQ:FLGC) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Flora Growth Corp. (NASDAQ:FLGC) Might Not Be As Mispriced As It Looks After Plunging 25%
To the annoyance of some shareholders, Flora Growth Corp. ( NASDAQ:FLGC ) shares are down a considerable 25% in the...Flora Growth Corp.'s (NASDAQ:FLGC) Price Is Right But Growth Is Lacking After Shares Rocket 28%
Flora Growth Corp. ( NASDAQ:FLGC ) shares have continued their recent momentum with a 28% gain in the last month alone...Health Check: How Prudently Does Flora Growth (NASDAQ:FLGC) Use Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 26% But It Can Do More
Flora Growth Corp. ( NASDAQ:FLGC ) shareholders would be excited to see that the share price has had a great month...Newsflash: Flora Growth Corp. (NASDAQ:FLGC) Analysts Have Been Trimming Their Revenue Forecasts
Today is shaping up negative for Flora Growth Corp. ( NASDAQ:FLGC ) shareholders, with the analysts delivering a...Slammed 27% Flora Growth Corp. (NASDAQ:FLGC) Screens Well Here But There Might Be A Catch
The Flora Growth Corp. ( NASDAQ:FLGC ) share price has softened a substantial 27% over the previous 30 days, handing...Flora Growth Corp.'s (NASDAQ:FLGC) Shares Leap 143% Yet They're Still Not Telling The Full Story
Flora Growth Corp. ( NASDAQ:FLGC ) shareholders would be excited to see that the share price has had a great month...Investors Don't See Light At End Of Flora Growth Corp.'s (NASDAQ:FLGC) Tunnel And Push Stock Down 51%
The Flora Growth Corp. ( NASDAQ:FLGC ) share price has softened a substantial 51% over the previous 30 days, handing...The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 41% But It Can Do More
Flora Growth Corp. ( NASDAQ:FLGC ) shares have had a really impressive month, gaining 41% after a shaky period...Investors Give Flora Growth Corp. (NASDAQ:FLGC) Shares A 28% Hiding
Flora Growth Corp. ( NASDAQ:FLGC ) shares have retraced a considerable 28% in the last month, reversing a fair amount...News Flash: Analysts Just Made A Meaningful Upgrade To Their Flora Growth Corp. (NASDAQ:FLGC) Forecasts
Flora Growth Corp. ( NASDAQ:FLGC ) shareholders will have a reason to smile today, with the analysts making substantial...Rendement voor aandeelhouders
| ZSTK | US Healthcare | US Markt | |
|---|---|---|---|
| 7D | 2.3% | -0.4% | 1.0% |
| 1Y | -84.4% | 16.3% | 28.7% |
Rendement versus industrie: ZSTK presteerde slechter dan de US Healthcare -sector, die het afgelopen jaar een rendement van 16.3 % opleverde.
Rendement versus markt: ZSTK presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 28.7 % opleverde.
Prijsvolatiliteit
| ZSTK volatility | |
|---|---|
| ZSTK Average Weekly Movement | 17.6% |
| Healthcare Industry Average Movement | 7.6% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiele aandelenkoers: De aandelenkoers van ZSTK is de afgelopen 3 maanden volatiel geweest in vergelijking met de US markt.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 18% ) van ZSTK is het afgelopen jaar stabiel geweest, maar is nog steeds hoger dan 75% van de aandelen US.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2019 | 21 | Daniel Reis-Faria | zerostack.ai |
ZeroStack Corp., via haar dochteronderneming Phatebo GmbH, is actief in de farmaceutische distributie in Duitsland. Het is actief via de segmenten Commercial & Wholesale en Digital Assets. Het bedrijf distribueert een scala aan farmaceutische goederen en medische producten voor de behandeling van verschillende gezondheidsindicaties, waaronder geneesmiddelen met betrekking tot kankertherapieën, attention-deficit/hyperactivity disorder, multiple sclerose en antidepressiva.
ZeroStack Corp. Samenvatting
| ZSTK fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$10.43m |
| Inkomsten(TTM) | -US$151.73m |
| Inkomsten(TTM) | US$36.08m |
Is ZSTK overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| ZSTK resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$36.08m |
| Kosten van inkomsten | US$31.82m |
| Brutowinst | US$4.26m |
| Overige uitgaven | US$155.99m |
| Inkomsten | -US$151.73m |
Laatst gerapporteerde inkomsten
Mar 31, 2026
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -62.43 |
| Brutomarge | 11.81% |
| Nettowinstmarge | -420.49% |
| Schuld/Eigen Vermogen Verhouding | 8.6% |
Hoe presteerde ZSTK op de lange termijn?
Bekijk historische prestaties en vergelijkingBedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/05/22 09:46 |
| Aandelenkoers aan het einde van de dag | 2026/05/22 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
ZeroStack Corp. wordt gevolgd door 2 analisten. 0 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Rommel Dionisio | Aegis Capital Corporation |
| William Kirk | Roth Capital Partners |